Total Payments
$1,803
2024 Payments
$956.98
Companies
17
Transactions
56
Medicare Patients
984
Medicare Billing
$52,687
Payment Breakdown by Category
Food & Beverage$1,677 (93.0%)
Travel$126.41 (7.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,677 | 55 | 93.0% |
| Travel and Lodging | $126.41 | 1 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $730.56 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $251.41 | 8 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $232.73 | 4 | $0 (2024) |
| Lilly USA, LLC | $161.92 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $67.96 | 4 | $0 (2024) |
| Novo Nordisk Inc | $66.73 | 3 | $0 (2024) |
| Inspire Medical Systems, Inc. | $50.57 | 2 | $0 (2024) |
| Genentech USA, Inc. | $38.32 | 4 | $0 (2021) |
| Abbott Laboratories | $35.27 | 2 | $0 (2024) |
| Amgen Inc. | $27.31 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $956.98 | 31 | Phathom Pharmaceuticals, Inc. ($232.73) |
| 2023 | $277.04 | 9 | ABBVIE INC. ($163.82) |
| 2022 | $518.44 | 11 | ABBVIE INC. ($416.62) |
| 2021 | $50.46 | 5 | Genentech USA, Inc. ($38.32) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $95.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes Care | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.47 | General |
| 07/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: VACCINE | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: DIABETES | ||||||
| 05/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes Care | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: RESPIRATORY | ||||||
| 04/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 03/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $118.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Obesity | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $110.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Biological | ||||||
| 03/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 13 | $2,678 | $520.76 |
| 2022 | 9 | 274 | 296 | $47,106 | $14,636 |
| 2021 | 9 | 322 | 338 | $35,160 | $15,805 |
| 2020 | 6 | 375 | 382 | $50,620 | $21,726 |
Total Patients
984
Total Services
1,029
Medicare Billing
$52,687
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,678 | $520.76 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 97 | $19,269 | $5,654 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $11,856 | $3,718 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 33 | $9,534 | $3,182 | 33.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 26 | $1,960 | $907.64 | 46.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 19 | $1,493 | $408.93 | 27.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 22 | $1,474 | $357.80 | 24.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 13 | 13 | $871.00 | $211.57 | 24.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 17 | $544.00 | $151.05 | 27.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 21 | $105.00 | $44.15 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 125 | $15,000 | $7,322 | 48.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $6,290 | $2,703 | 43.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 34 | 34 | $4,080 | $1,585 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $3,040 | $1,501 | 49.4% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 37 | 39 | $2,340 | $1,378 | 58.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 19 | $1,710 | $690.17 | 40.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 24 | 24 | $1,200 | $439.56 | 36.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 14 | $1,050 | $118.96 | 11.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 27 | 30 | $450.00 | $67.50 | 15.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 111 | 114 | $13,555 | $6,770 | 49.9% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 103 | 103 | $12,360 | $6,657 | 53.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 72 | $13,680 | $4,233 | 30.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 58 | 58 | $9,860 | $3,893 | 39.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 12 | $820.00 | $121.56 | 14.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 23 | 23 | $345.00 | $51.30 | 14.9% |
About Evelyn Asante, NP
Evelyn Asante, NP is a Nurse Practitioner healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639165004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Evelyn Asante, NP has received a total of $1,803 in payments from pharmaceutical and medical device companies, with $956.98 received in 2024. These payments were reported across 56 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,677).
As a Medicare-enrolled provider, Asante has provided services to 984 Medicare beneficiaries, totaling 1,029 services with total Medicare billing of $52,687. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Providence, RI
- Active Since 09/21/2005
- Last Updated 07/08/2007
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1639165004
Products in Payments
- UBRELVY (Drug) $363.80
- VOQUEZNA (Drug) $232.73
- FARXIGA (Drug) $209.86
- RINVOQ (Biological) $202.94
- QULIPTA (Drug) $148.00
- MOUNJARO (Drug) $139.38
- TRELEGY ELLIPTA (Drug) $67.96
- INSPIRE (Device) $50.57
- Wegovy (Drug) $42.26
- Xofluza (Drug) $38.32
- FREESTYLE LIBRE 3 (Device) $35.27
- EVENITY (Biological) $27.31
- TRADJENTA (Drug) $25.48
- GEMTESA (Drug) $24.02
- EMGALITY (Drug) $22.54
- XIFAXAN (Drug) $22.25
- BREZTRI (Drug) $22.02
- Cologuard Collection Kit (Device) $21.22
- Veozah (Drug) $19.73
- AIRSUPRA (Drug) $19.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Providence
Mrs. Lea Kelly, Np-C, NP-C
Nurse Practitioner — Payments: $3,925
Nurse Practitioner $3,925
Samira Ouklilane, Np, NP
Nurse Practitioner — Payments: $2,758
Nurse Practitioner $2,758
Kathy Vincent, Aprn, Np-Bc, APRN, NP-BC
Nurse Practitioner — Payments: $2,363
Nurse Practitioner $2,363
Natalie Gibson, Dnp, DNP
Nurse Practitioner — Payments: $2,252
Nurse Practitioner $2,252
Florette Fils-Aima
Nurse Practitioner — Payments: $1,977
Nurse Practitioner $1,977
Winona Lambdin, Rn, RN
Nurse Practitioner — Payments: $1,440
Nurse Practitioner $1,440